2021 Q3 Form 10-Q Financial Statement

#000109181821000140 Filed on October 28, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2020 Q3 2020 Q2
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $20.02K $3.300K $3.300K
YoY Change 506.79%
Operating Profit -$20.02K -$3.300K
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$20.02K -$3.300K -$3.300K
YoY Change 506.79%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 47.23M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q3 2020 Q3 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $1.700K $1.700K $1.700K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$5.400K -$99.20K -$96.20K
YoY Change
Total Liabilities & Shareholders Equity
YoY Change

Cashflow Statement

Concept 2021 Q3 2020 Q3 2020 Q2
OPERATING ACTIVITIES
Net Income -$20.02K -$3.300K -$3.300K
YoY Change 506.79%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0000894501
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
75087284 shares
us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
30000 USD
us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
30000 USD
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
47227500 shares
CY2021Q3 grhi Consulting Fees Expenses
ConsultingFeesExpenses
3000 USD
CY2020Q3 grhi Consulting Fees Expenses
ConsultingFeesExpenses
3000 USD
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2021Q3 us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
USD
CY2020Q3 us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
USD
grhi Consulting Fees Expenses
ConsultingFeesExpenses
9000 USD
grhi Consulting Fees Expenses
ConsultingFeesExpenses
9000 USD
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17024 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
300 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
41927 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
900 USD
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
20024 USD
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
3300 USD
us-gaap Operating Expenses
OperatingExpenses
80927 USD
us-gaap Operating Expenses
OperatingExpenses
39900 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-20024 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-3300 USD
us-gaap Net Income Loss
NetIncomeLoss
-80927 USD
us-gaap Net Income Loss
NetIncomeLoss
-39900 USD
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
87290368 shares
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
47227500 shares
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
3100 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
USD
grhi Common Shares Issued For Consulting
CommonSharesIssuedForConsulting
3000 USD
grhi Common Shares Issued For Consulting
CommonSharesIssuedForConsulting
USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
38627 USD
grhi Common Shares Issued For Consulting1
CommonSharesIssuedForConsulting1
29000 USD
grhi Common Shares Issued For Consulting1
CommonSharesIssuedForConsulting1
USD
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-100 USD
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
6100 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
8600 USD
grhi Increase Decrease In Accrued Board Of Directors Compensation
IncreaseDecreaseInAccruedBoardOfDirectorsCompensation
-1000 USD
grhi Increase Decrease In Accrued Board Of Directors Compensation
IncreaseDecreaseInAccruedBoardOfDirectorsCompensation
-30000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-38627 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1300 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
USD
us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
38627 USD
us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
1300 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1300 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1700 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1700 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1700 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1700 USD
us-gaap Interest Paid
InterestPaid
USD
us-gaap Interest Paid
InterestPaid
USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-60600 USD
grhi Capital Contributions Director
CapitalContributionsDirector
1300 USD
us-gaap Net Income Loss
NetIncomeLoss
-39900 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-99200 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-102200 USD
grhi Stock Issued During Period Value For Accrued Expenses Directors Fees
StockIssuedDuringPeriodValueForAccruedExpensesDirectorsFees
104000 USD
grhi Stock Issued During Period Value For Consulting And Director Compensation
StockIssuedDuringPeriodValueForConsultingAndDirectorCompensation
32000 USD
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
3100 USD
grhi Capital Contributions Director
CapitalContributionsDirector
38627 USD
us-gaap Net Income Loss
NetIncomeLoss
-80927 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-5400 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-96200 USD
CY2020Q3 grhi Capital Contributions Director
CapitalContributionsDirector
300 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-3300 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-99200 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-9254 USD
CY2021Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
3100 USD
CY2021Q3 grhi Capital Contributions Director
CapitalContributionsDirector
20778 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-20024 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-5400 USD
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Use of Estimates</span></p> <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. </p>
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
850000000 shares
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
38627 USD
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
1300 USD
grhi Increase Decrease In Additional Paid In Capital
IncreaseDecreaseInAdditionalPaidInCapital
38627 USD
grhi Increase Decrease In Additional Paid In Capital
IncreaseDecreaseInAdditionalPaidInCapital
1300 USD
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
850000000 shares
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
47227500 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
47227500 shares

Files In Submission

Name View Source Status
0001091818-21-000140-index-headers.html Edgar Link pending
0001091818-21-000140-index.html Edgar Link pending
0001091818-21-000140.txt Edgar Link pending
0001091818-21-000140-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
grhi-20210930.xsd Edgar Link pending
grhi-20210930_cal.xml Edgar Link unprocessable
grhi-20210930_def.xml Edgar Link unprocessable
grhi-20210930_lab.xml Edgar Link unprocessable
grhi-20210930_pre.xml Edgar Link unprocessable
grhi10q0921.htm Edgar Link pending
grhi10q0921_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending